VALEANT PHARMACEUTICALS $74.23

down -0.59


23/5/2013 09:23 AM  |  NYSE : VRX  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 57% - VRX has outperformed the S&P 500 by 33%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by

Ticker Name Weight % Change
No ETF alternatives available.


People viewing VRX also viewed: , , , ,

Competitors

Ticker Name Volume % Change
IRBS IR BIOSCIENCES HOLDINGS 57.6K +1.00%
GGCO GHANA GOLD 49.9K +0.28%
KVPHQ K-V PHARMACEUTICAL 650.0 +0.17%
PRPH PROPHASE LABS 42.0K +0.16%
IMMD IMMUDYNE 2.0K +0.09%

VRX Stock Analysis

  1. A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap

    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
  2. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    Teva's partnership with Alexza looks like an expensive gamble.
Free Reports
  1. Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
  2. Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
  3. FREE Options Trading Manual

    If you are new to the options market, this free booklet is designed for you!
Marketplace
Trading Center